fowlpox-gm-csf
Biologicalexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2003 (NCT00060528)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fowlpox-gm-csf
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00096551 | Phase 1 | Nov 1, 2004 | National Cancer Institute (NCI) |
| NCT00081848 | Phase 1 | Apr 20, 2004 | National Cancer Institute (NCI) |
| NCT00060528 | Phase 1/Phase 2 (Phase 2) | May 1, 2003 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 3 | 3 | 2 | 2003 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2003 |
2 organizations
Page 1 / 1